Mercia launches new biotech company
Seed investor The Mercia Fund has spun out a new venture, the Native Antigen Company (NAC), from existing portfolio company PsiOxus Therapeutics.
News
Seed investor The Mercia Fund has spun out a new venture, the Native Antigen Company (NAC), from existing portfolio company PsiOxus Therapeutics.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software